Development of the gamma-aminobutyric acid neurotransmitter system in the rat cerebral cortex during repeated administration of the GABA-transaminase inhibitor ethanolamine O-sulphate.
C C Sykes, R W Horton
Index: J. Neurochem. 46(1) , 213-7, (1986)
Full Text: HTML
Abstract
Ethanolamine O-sulphate (400 mg/kg, i.p.) was administered to rat pups at 9 days of age and on alternate days up to 17 days of age. At 18 days of age, gamma-aminobutyric acid (GABA) concentration was increased (three- to fourfold), glutamic acid decarboxylase (GAD) activity reduced to 55% of control, and the number of GABAA and GABAB binding sites increased in the cerebral cortex. This is the same pattern of change as seen previously with oral administration of ethanolamine O-sulphate to the adult rat but the changes occur more rapidly in the developing rat. A lower dose of ethanolamine O-sulphate (100 mg/kg, i.p.), administered according to the same schedule, caused a twofold increase in cortical GABA at 18 days of age whereas GAD activity and GABAA binding were not significantly altered.
Related Compounds
Related Articles:
2006-10-01
[Anal. Bioanal. Chem 386(3) , 666-74, (2006)]
1995-05-01
[J. Neurochem. 64 , 2256, (1995)]
GABA-mimetic compounds block haloperidol-induced hyperprolactinemia in rats.
1986-01-01
[Adv. Biochem. Psychopharmacol. 42 , 139-44, (1986)]
New urea-based surfactants derived from alpha,omega-amino acids.
2009-01-29
[J. Phys. Chem. B 113(4) , 977-82, (2009)]
1990-01-01
[Life Sci. 46(22) , 1587-95, (1990)]